Dr Scott Stanley

News, Articles, Videos and other content about Dr Scott Stanley

RMTC Board Names Interim Director

At its April 23 meeting the Racing Medication and Testing Consortium board of directors approved an agreement with The Jockey Club to engage the full-time services of Jamie Haydon as RMTC interim executive director.

Drug Testing, Prosecution Focus of Conference

A seminar focused on drug testing and the prosecution of a medication case will be the focus of the Racing Officials Accreditation Programfs second annual Officiating Horse Racing Conference at the University of Arizona Race Track Industry Programfs Symposium on Racing and Gaming.

CHRB Seeks Comments on Steroids Rules

CHRB Seeks Comments on Steroids Rules

The California Horse Racing Board will vote in July on regulatory changes that would result in stricter penalties for anabolic steroids violations, and is soliciting public comment prior to a July 17 hearing at Del Mar.

RMTC Strives for Uniform Drug Testing

RMTC Strives for Uniform Drug Testing

The Racing Medication and Testing Consortium sponsored an equine racing chemist workshop to foster uniformity in drug testing of the androgenic anabolic steroids from April 27-30 at the University of California at Davis.

RMTC Board Recommends Steroid Policy

  • News
RMTC Board Recommends Steroid Policy

The board of directors of the Racing Medication and Testing Consortium (RMTC), in consultation with the RMTC Scientific Advisory Committee, approved policy recommendations for the use of steroids. The action took place at an RMTC board meeting March 25 Austin, Texas.

Commentary: Adjusting the Focus

By Dr. Scott Stanley and Dr. Rick Arthur - Horse racing was ahead of other sports in implementing a drug-testing program, and in many ways we are still the paceĀ­setters. We cast a broader net for more drugs than any other sport.

Committee to Look at California Medication Thresholds

The National Horsemen's Benevolent and Protective Association Medication Committee will review California research that helped develop thresholds for two therapeutic medications during its meeting July 14 in Bloomington, Minn., as part of the National HBPA summer convention.

Most Popular Stories